Plenum Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.45 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.00 M
as on 16-11-2024
- Revenue -3.18%
(FY 2023)
- Profit -3.22%
(FY 2023)
- Ebitda 3.23%
(FY 2023)
- Net Worth 27.18%
(FY 2023)
- Total Assets 61.05%
(FY 2023)
About Plenum Biotech
The Corporate was formerly known as Spa Newtraceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.45 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Sharda and Rahul Khosla serve as directors at the Company.
- CIN/LLPIN
U24290CH2012PTC033665
- Company No.
033665
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2012
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Plenum Biotech Private Limited offer?
Plenum Biotech Private Limited offers a wide range of products and services, including Dietary Supplements, S-Adenosylmethionine Tablets, Pharma Franchise, Pharmaceutical Distributors, Omega 3 Capsule, Ayurvedic PCD Pharma Franchise, Third Party Manufacturing Consultancy, Pharmaceutical Third Party Manufacturing, Antibiotic Injection, Ceftriaxone Injection.
Who are the key members and board of directors at Plenum Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Khosla  | Director | 01-Dec-2015 | Current |
| Neeraj Sharda | Director | 27-Mar-2012 | Current |
Financial Performance of Plenum Biotech.
Plenum Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.18% decrease. The company also saw a slight decrease in profitability, with a 3.22% decrease in profit. The company's net worth Soared by an impressive increase of 27.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plenum Biotech?
In 2023, Plenum Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 07 Nov 2022 | ₹2.45 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Dec 2021 | ₹4.00 M | Satisfied |
How Many Employees Work at Plenum Biotech?
Unlock and access historical data on people associated with Plenum Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plenum Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plenum Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
